It’s been already reported that the very first COVID-19 vaccine that’s been tested in the US managed to revamp people’s immunity just the way in which experts were hoping when they created it.
“No matter how you slice this, this is good news,” Dr. Anthony Fauci, the U.S. government’s top infectious disease expert recently said.
CBS News noted the following: “The experimental vaccine, developed by Fauci’s colleagues at the National Institutes of Health and Moderna Inc., will start its most important step around July 27: A 30,000-person study to prove if the shots really are strong enough to protect against the coronavirus.”
During a recent conference call in which there’s been a discussion to encourage the phase 1 trial results for mRNA-1273, CEO Stephane Bancel addressed a plan to produce enough doses to vaccinate everybody in the U.S.
It seems thayt the company is confident that it can produce between 500 million and 1 billion doses annually. “At the moment, Moderna and its manufacturing partners are producing doses of mRNA-1273 at three sites for the U.S. market,” according to the latest reports.
Successful results of treatments
As you already know, experts from all over the world have joined efforts to create viable treatments for COVID-19. Not too long ago, it’s been reported that there’s an exciting medicine that has the ability to downgrade the danger levels of coronavirus to the ones of a simple, common cold. This is what a Jwerusalen researcher has been claiming after he tested it on infected human tissue.
As a conclusion, seeing more good news about the fight against the novel coronavirus comes like a breath of fresh air amidst the global crisis that’s been triggered by this terrible pandemic that disrupted our normal everyday lives.
Not too long ago, there’s been also debated the fact that the novel coronavirus could feed away on its own and the newly discovered strains are becoming weaker and weaker.
